HALO - Company ID 0001159036
As of 2026-11-06, HALOZYME THERAPEUTICS, INC. (HALO) has a market capitalization of $12.38 B, making it the #813 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $12.38 B |
| 2026-11-05 | $15.46 B |
| 2026-11-04 | $15.53 B |
| 2026-11-03 | $15.26 B |
| 2026-11-02 | $15.23 B |
| 2026-11-01 | $15.53 B |
| 2026-10-31 | $15.53 B |
| 2026-10-30 | $15.51 B |
| 2026-10-29 | $15.53 B |
| 2026-10-28 | $15.42 B |
| 2026-10-27 | $15.24 B |
| 2026-10-26 | $15.18 B |
As of 2026-11-06, HALOZYME THERAPEUTICS, INC. (HALO) has a market capitalization of $12.38 B, making it the #813 most valuable US-listed company.
HALOZYME THERAPEUTICS, INC. is the #813 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $14.90 B |
| 2026-10-24 | $14.90 B |
| 2026-10-23 | $14.90 B |
| 2026-10-22 | $14.77 B |
| 2026-10-21 | $14.81 B |
| 2026-10-20 | $14.75 B |
| 2026-10-19 | $14.53 B |
| 2026-10-18 | $14.45 B |
| 2026-10-17 | $14.45 B |
| 2026-10-16 | $14.36 B |
| 2026-10-15 | $14.41 B |
| 2026-10-14 | $13.86 B |
| 2026-10-13 | $12.94 B |
| 2026-10-12 | $13.21 B |
| 2026-10-11 | $13.10 B |
| 2026-10-10 | $13.10 B |
| 2026-10-09 | $13.10 B |
| 2026-10-08 | $13.09 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.